Prediction of individual compounds forming activity cliffs using emerging chemical patterns

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Activity cliffs, defined by significant potency differences in structurally similar compounds, are crucial for structure-activity relationship (SAR) analysis and optimizing drug candidates.
• Previous methods for identifying activity cliffs were primarily descriptive, relying on analyzing existing compound datasets and activity landscape representations.
• Recent efforts have shifted towards predictive approaches, developing computational models to distinguish between compound pairs that form activity cliffs and those that do not.

Purpose of the Study:

• To address the challenge of predicting individual compounds, rather than pairs, that are likely to be involved in activity cliffs.
• To develop a computational method capable of accurately predicting single compounds that exhibit high or low potency, indicative of participation in activity cliffs.

Main Methods:

• Development of computational models focused on predicting individual compounds associated with activity cliffs.
• Utilizing emerging chemical patterns as the basis for these predictive models.
• Training and validating models to accurately classify compounds based on their potential to form activity cliffs.

Main Results:

• Demonstrated the accurate prediction of individual compounds that can form activity cliffs.
• Successfully identified high and low potency compounds likely to be part of activity cliffs based on chemical patterns.
• Established a novel predictive approach moving beyond descriptive analysis of activity cliffs.

Conclusions:

• Predicting individual compounds involved in activity cliffs is feasible using computational methods based on chemical patterns.
• This predictive capability offers a significant advancement for medicinal chemistry, enabling more efficient compound optimization.
• The study provides a new tool for proactively identifying critical compounds in drug discovery pipelines.